Diacylglycerol Signaling

178 J.D. Black
Alisi, A., Spagnuolo, S., Napoletano, S., Spaziani, A., & Leoni, S. (2004). Thyroid hormones
regulate DNA-synthesis and cell-cycle proteins by activation of PKCalpha and p42/44 MAPK
in chick embryo hepatocytes. J Cell Physiol, 201, 259–265.
Arita, Y., Buffolino, P., & Coppock, D. L. (1998). Regulation of the cell cycle at the G2/M boundary
in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking
p34cdc2 kinase activity. Exp Cell Res, 242, 381–390.
Ashton, A. W., Watanabe, G., Albanese, C., Harrington, E. O., Ware, J. A., & Pestell, R. G.
(1999). Protein kinase Cdelta inhibition of S-phase transition in capillary endothelial cells
involves the cyclin-dependent kinase inhibitor p27(Kip1). J Biol Chem, 274,
20805–20811.
Asiedu, C., Biggs, J., & Kraft, A. S. (1997). Complex regulation of CDK2 during phorbol esterinduced
hematopoietic differentiation. Blood, 90, 3430–3437.
Asiedu, C., Biggs, J., Lilly, M., & Kraft, A. S. (1995). Inhibition of leukemic cell growth by the
protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent
kinase 2. Cancer Res, 55, 3716–3720.
Bae, K. M., Wang, H., Jiang, G., Chen, M. G., Lu, L., & Xiao, L. (2007). Protein kinase C epsilon
is overexpressed in primary human non-small cell lung cancers and functionally required for
proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res,
67, 6053–6063.
Balciunaite, E., Jones, S., Toker, A., & Kazlauskas, A. (2000). PDGF initiates two distinct phases
of protein kinase C activity that make unequal contributions to the G0 to S transition. Curr
Biol, 10, 261–267.
Balciunaite, E., & Kazlauskas, A. (2001). Early phosphoinositide 3-kinase activity is required for
late activation of protein kinase Cepsilon in platelet-derived-growth-factor-stimulated cells:
evidence for signalling across a large temporal gap. Biochem J, 358, 281–285.
Balciunaite, E., & Kazlauskas, A. (2002). The timing and extent of activation of diacylglycerolresponsive
protein kinase-cs determines their ability to inhibit or promote platelet-derived
growth factor-dependent DNA synthesis. Exp Cell Res, 281, 167–174.
Barboule, N., Lafon, C., Chadebech, P., Vidal, S., & Valette, A. (1999). Involvement of p21 in the
PKC-induced regulation of the G2/M cell cycle transition. FEBS Lett, 444, 32–37.
Barth, H., Hoffmann, I., Klein, S., Kaszkin, M., Richards, J., & Kinzel, V. (1996). Role of cdc25-C
phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth
factor and phorbolester. J Cell Physiol, 168, 589–599.
Barth, H., & Kinzel, V. (1994). Phorbol ester TPA rapidly prevents activation of p34cdc2 histone
H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa
cells. Exp Cell Res, 212, 383–388.
Berthet, C., & Kaldis, P. (2007). Cell-specific responses to loss of cyclin-dependent kinases.
Oncogene, 26, 4469–4477.
Besson, A., & Yong, V. W. (2000). Involvement of p21(Waf1/Cip1) in protein kinase C alphainduced
cell cycle progression. Mol Cell Biol, 20, 4580–4590.
Bi, N., & Mamrack, M. D. (1994). PMA inhibits the growth of human fibroblasts after the induction
of immediate-early genes. Exp Cell Res, 212, 105–112.
Biggs, J. R., Kudlow, J. E., & Kraft, A. S. (1996). The role of the transcription factor Sp1 in regulating
the expression of the WAF1/CIP1 gene in U937 leukemic cells. J Biol Chem, 271, 901–906.
Bikle, D. D., Ng, D., Tu, C. L., Oda, Y., & Xie, Z. (2001). Calcium- and vitamin D-regulated
keratinocyte differentiation. Mol Cell Endocrinol, 177, 161–171.
Black, J. D. (2000). Protein kinase C-mediated regulation of the cell cycle. Front Biosci, 5,
D406–D423.
Black, J. D. (2001). Protein kinase C isozymes in colon carcinogenesis: guilt by omission.
Gastroenterology, 120, 1868–1872.
Black, A. R., Curry, K. J., & Black, J. D. Unpublished data.
Borner, C., Filipuzzi, I., Weinstein, I. B., & Imber, R. (1991). Failure of wild-type or a mutant
form of protein kinase C-alpha to transform fibroblasts. Nature, 353, 78–80.